Signed in as:
filler@godaddy.com
We turn badly behaved molecules into smart formulations.
We are an award winning formulation development CDMO. We turn badly behaved molecules into smart formulations which gives them the best chance of success in preclinical studies, and enables them to be accelerated to clinic and commercial.
Our core expertise is in developing formulations for small molecules and peptides for a range of routes of administration including: oral, ocular, intranasal and topical.
When developing formulations we consider:
How badly behaved is the molecule? What are the characteristics which need to be formulated out or around? For example, poor solubility, permeability, stability and/or release profile.
How far does the client want to take the product? For example GLP tox, Phase I, Phase II, commercial? How futureproof does the formulation need to be?
What are the imminent study requirements? For example dose, route of administration and, of course, the timelines?
What species will the formulations be assessed in? This will help us to determine which formats can be used and select excipients at appropriate levels.
Our Futureproof Formulations Fast™ approach creates formulations which give the molecule the best chance of success in the imminent studies, and enable it to be accelerated on to clinic.
All activities are fee for service, all IP generated belongs to the Client.
We know that our Clients have unique needs. Send us a message, and we will get back to you soon.
MediCity D6 Building, Thane Road, Nottingham, Nottinghamshire, NG90 6BH, United Kingdom
Agility Life Sciences
MediCity D6 Building, Thane Road, Nottingham, Nottinghamshire, NG90 6BH
Copyright © 2024 Agility Life Sciences - All Rights Reserved.